Study of Lacutamab in Peripheral T-cell Lymphoma

NCT04984837 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cell Lymphoma
Relapse/Recurrence

Interventions

DRUG: Lacutamab
DRUG: Gemcitabine
DRUG: Oxaliplatine

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]